View clinical trials related to Schizophrenia Patients.
Filter by:The primary objectives of the study are to characterize the pharmacokinetic (PK) profiles of paliperidone in LY03010 P1 and P2 following a single IM injection in schizophrenia patients and to compare the PK of LY03010 P1 and P2 with that of INVEGA SUSTENNA® following a single IM injection of 156 mg dosage level.
A Phase I, Drug-Drug Interaction Study between Midazolam and Lurasidone HCl.